09:00AM - 09:07AM
Sustained Weight Reduction by
Thresholds in Adults with Obesity and Prediabetes Treated with Tirzepatide over 176
weeks (SURMOUNT-1)
09:08AM - 09:15AM
Changes in CGM Metrics for
People with T2D Switching from Dulaglutide or Semaglutide to Tirzepatide 5mg A
Sub-Analysis of The Surpass-Switch-2 Study
Swati Choudhary
(Gurgaon)
09:16AM - 09:23AM
VerSemaglutide: The Versatile
Semaglutide
Dhruvil U Gajera
(Ahmedabad)
09:24AM - 09:31AM
Physicochemical Evaluation
and Multimedia Dissolution Profile of Metformin HCl Granules for Oral Solution: A
Patient-Centric Alternative to Tablets
09:32AM - 09:39AM
Evaluating the Correlation
Between Time-in-Range (TIR) and Glycemia Risk Index (GRI) Using Continuous Glucose
Monitoring (CGM) in Indian Patients with Diabetes
Abhijit Trailokya
(Mumbai)
09:40AM - 09:47AM
Real-World Effectiveness of
Vildagliptin SR in Indian Young-Onset T2DM: NOVELTY Insights
09:48AM - 09:55AM
The Role of Automated Insulin
Delivery Technology in Diabetes
Manish Agarwal
(Ahmedabad)
09:56AM - 10:03AM
Discordantly elevated HbA1c
in a well-controlled diabetic patient: a rare case of interference by elevated fetal
hemoglobin
Dr. Arppana Thomas
(Ernakulam)
10:04AM - 10:11AM
Efficacy and safety of
dapagliflozin and linagliptin combination in individuals with type 2 diabetes
mellitus: A meta-analysis of randomized controlled trials
Madhulika Bolshete
(Pune)
10:12AM - 10:19AM
Risk of Obstructive Sleep
Apnea in diabetic population
10:20AM - 10:27AM
The Association Between PM2.5
Exposure and Diabetes: An Umbrella Review of Systematic Reviews and Meta-Analyses
Yashendra Sethi
(Dehradun)
10:28AM - 10:35AM
The use of technology in type
2 diabetes and prediabetes: a narrative review
Manish Agarwal
(Ahmedabad)
10:36AM - 10:43AM
Diabetic Myonecrosis in
India's Growing Diabetic Population : A Case for Clinical Vigilance
Aswin Radhakrishnan
(Kozhikode)
10:44AM - 10:51AM
Uncontrolled diabetes as a
harbinger of disseminated melioidosis : a diagnostic Odyssey
Prasanth P. Dev
(Kottayam)
10:52AM - 10:59AM
Effect of DPP4 Inhibitors on
Microvascular Outcomes: A Meta-analysis of Cardiovascular Outcome Trials
Divyanshu Prajapati
(Ahmedabad)
11:00AM - 11:07AM
Impact of Baseline BMI on
Effectiveness and Safety of Telmisartan/Amlodipine FDC in Indian patients with
Hypertension: Subgroup analysis of TACT India Real-world study
Jabir Abdullakutty
(Kochi)
11:08AM - 11:15AM
Optimizing Type 2 Diabetes
Care: Utilization Patterns of Linagliptin, Dapagliflozin & Metformin Combination
therapy
11:16AM - 11:23AM
Real-Time CGM-Driven Coaching
Improves Glycemic Outcomes in Adults with Type 2 Diabetes: Findings from a
Randomized Trial
Shivtosh Kumar
(Bengaluru)
11:24AM - 11:31AM
Gender - Based Organ
susceptibility in type 2 Diabetes mellitus using Ralph A. DeFronzo's Ominous Octet
Model
Zohra Farooque Khan
(Mumbai)
11:32AM - 11:39AM
Case of acromegaly presenting
as diabetes
11:40AM - 11:47AM
Future of Generative AI in Healthcare
Manish Agarwal
(Ahmedabad)
11:48AM - 11:55AM
Effectiveness of Community
Health Worker-led Diabetes Care Models on Glycemic Control in Rural East Indian
Populations
Mohammad Dilawez Shamim
(Chapra)
11:56AM - 12:03PM
Redefining Prediabetes : From
Glucose Centric to Multi-System Disease Model - A Paradigm shift in Early Metabolic
Syndrome Management
Shubhashree Patil
(Mumbai)
12:04PM - 12:11PM
Impact of duration of
diabetes on ElectroCardioGraphic (ECG) changes in patients with type 2 diabetes
mellitus.
12:12PM - 12:19PM
Correlation of C Peptide With Duration of Type 2 Diabetes
Satyavamsi Gadde
(Mangaluru)
12:20PM - 12:27PM
The ATLAS Study- South India
Study on Association of Fatty Liver and Diabetes – Exploring Metabolic Markers and
Risk Factors
12:28PM - 12:35PM
Comparison of SGLT2
inhibitors for CV outcomes T2DM Patients with Established ASCVD: A Network
Meta-Analysis (EmphaNet-ASCVD)
Sandesh Warudkar
(Ahmedabad)
12:36PM - 12:43PM
Pattern and trends of
diabetes mellitus in rural population under 40yrs of age: Is this just the tip of
iceberg.
Vikas Chandra Vidyarthi
(Lucknow)
12:44PM - 12:51PM
Effect of Finerenone versus
SGLT2 inhibitors on Cardiovascular and Renal Outcomes in T2DM and CKD: A Systematic
Review and Network Meta-analysis
12:52PM - 12:59PM
Diabetes With Non-HDL Cholesterol
Manish Agarwal
(Ahmedabad)